Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

78 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Development of a Novel Imaging Agent for Determining Albumin Uptake in Solid Tumors.
Daum S, Magnusson JP, Pes L, Garcia Fernandez J, Chercheja S, Medda F, Nollmann FI, Koester SD, Perez Galan P, Warnecke A, Abu Ajaj K, Kratz F. Daum S, et al. Among authors: perez galan p. Nucl Med Mol Imaging. 2019 Jun;53(3):189-198. doi: 10.1007/s13139-019-00587-w. Epub 2019 Feb 20. Nucl Med Mol Imaging. 2019. PMID: 31231439 Free PMC article.
Novel auristatin E-based albumin-binding prodrugs with superior anticancer efficacy in vivo compared to the parent compound.
Pes L, Koester SD, Magnusson JP, Chercheja S, Medda F, Abu Ajaj K, Rognan D, Daum S, Nollmann FI, Garcia Fernandez J, Perez Galan P, Walter HK, Warnecke A, Kratz F. Pes L, et al. Among authors: perez galan p. J Control Release. 2019 Feb 28;296:81-92. doi: 10.1016/j.jconrel.2019.01.010. Epub 2019 Jan 11. J Control Release. 2019. PMID: 30639692
Patient-derived follicular lymphoma spheroids recapitulate lymph node signaling and immune profile uncovering galectin-9 as a novel immunotherapeutic target.
Dobaño-López C, Valero JG, Araujo-Ayala F, Nadeu F, Gava F, Faria C, Norlund M, Morin R, Bernes-Lasserre P, Arenas F, Grau M, López C, López-Oreja I, Serrat N, Martínez-Farran A, Hernández L, Playa-Albinyana H, Giménez R, Beà S, Campo E, Lagarde JM, López-Guillermo A, Magnano L, Colomer D, Bezombes C, Pérez-Galán P. Dobaño-López C, et al. Among authors: perez galan p. Blood Cancer J. 2024 May 2;14(1):75. doi: 10.1038/s41408-024-01041-7. Blood Cancer J. 2024. PMID: 38697976 Free article.
Patient-derived lymphoma spheroids integrating immune tumor microenvironment as preclinical follicular lymphoma models for personalized medicine.
Faria C, Gava F, Gravelle P, Valero JG, Dobaño-López C, Van Acker N, Quelen C, Jalowicki G, Morin R, Rossi C, Lagarde JM, Fournié JJ, Ysebaert L, Laurent C, Pérez-Galán P, Bezombes C. Faria C, et al. Among authors: perez galan p. J Immunother Cancer. 2023 Oct;11(10):e007156. doi: 10.1136/jitc-2023-007156. J Immunother Cancer. 2023. PMID: 37899130 Free PMC article.
A novel patient-derived 3D model recapitulates mantle cell lymphoma lymph node signaling, immune profile and in vivo ibrutinib responses.
Araujo-Ayala F, Dobaño-López C, Valero JG, Nadeu F, Gava F, Faria C, Norlund M, Morin R, Bernes-Lasserre P, Serrat N, Playa-Albinyana H, Giménez R, Campo E, Lagarde JM, López-Guillermo A, Gine E, Colomer D, Bezombes C, Pérez-Galán P. Araujo-Ayala F, et al. Among authors: perez galan p. Leukemia. 2023 Jun;37(6):1311-1323. doi: 10.1038/s41375-023-01885-1. Epub 2023 Apr 8. Leukemia. 2023. PMID: 37031299 Free PMC article.
Venetoclax improves CD20 immunotherapy in a mouse model of MYC/BCL2 double-expressor diffuse large B-cell lymphoma.
Melchor J, Garcia-Lacarte M, Grijalba SC, Arnaiz-Leché A, Pascual M, Panizo C, Blanco O, Segura V, Novo FJ, Valero JG, Pérez-Galán P, Martinez-Climent JA, Roa S. Melchor J, et al. Among authors: perez galan p. J Immunother Cancer. 2023 Feb;11(2):e006113. doi: 10.1136/jitc-2022-006113. J Immunother Cancer. 2023. PMID: 36854569 Free PMC article.
Interleukin-1 receptor associated kinase 1/4 and bromodomain and extra-terminal inhibitions converge on NF-κB blockade and display synergistic antitumoral activity in activated B-cell subset of diffuse large B-cell lymphoma with MYD88 L265P mutation.
Dlouhy I, Armengol M, Recasens-Zorzo C, Ribeiro ML, Pérez-Galán P, Bosch F, López-Guillermo A, Roué G. Dlouhy I, et al. Among authors: perez galan p. Haematologica. 2022 Dec 1;107(12):2990. doi: 10.3324/haematol.2022.281988. Haematologica. 2022. PMID: 36453521 Free PMC article. No abstract available.
Blocking GM-CSF receptor α with mavrilimumab reduces infiltrating cells, pro-inflammatory markers and neoangiogenesis in ex vivo cultured arteries from patients with giant cell arteritis.
Corbera-Bellalta M, Alba-Rovira R, Muralidharan S, Espígol-Frigolé G, Ríos-Garcés R, Marco-Hernández J, Denuc A, Kamberovic F, Pérez-Galán P, Joseph A, D'Andrea A, Bondensgaard K, Cid MC, Paolini JF. Corbera-Bellalta M, et al. Among authors: perez galan p. Ann Rheum Dis. 2022 Apr;81(4):524-536. doi: 10.1136/annrheumdis-2021-220873. Epub 2022 Jan 19. Ann Rheum Dis. 2022. PMID: 35045965 Free PMC article.
78 results